AxoGen, Inc. (AXGN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

AxoGen, Inc. (AXGN) is up 20.6% since the beginning of the year. At $39 per share, AXGN is trading 13.9% below its 52-week high of $46. Investors who bought $1,000 worth of AXGN shares 5 years ago would now be looking at an investment worth $2,088.

AxoGen, Inc. (AXGN) has returned 20.56% so far this year and 247.36% over the past 12 months. Looking at the last ten years, AXGN has achieved an annualized return of 21.30%, outperforming the S&P 500 Index benchmark, which averaged 13.75% per year.

Based on dividend-adjusted daily data since Mar 27, 1990, AXGN's average daily return is +0.32%, while the average monthly return is +2.94%. At this rate, an investment would double in approximately 2.0 years.

Historically, 47% of months were positive and 53% were negative. The best month was May 2007 with a return of +225.0%, while the worst month was Jul 2002 at -51.3%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, AXGN closed higher 38% of trading days. The best single day was Apr 30, 2003 with a return of +150.0%, while the worst single day was Feb 13, 2003 at -58.8%.

AxoGen, Inc. has an annualized alpha of 115.64%, beta of 0.48, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 28, 1990.

• This stock participated in 54.62% of S&P 500 Index downside but only 53.35% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.48 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

AXGN ranks 98 for risk / return — in the top 98% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for AxoGen, Inc. (AXGN) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the AxoGen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AxoGen, Inc. was 98.49%, occurring on Aug 16, 2002. Recovery took 3701 trading sessions.

The current AxoGen, Inc. drawdown is 29.41%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of AxoGen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how AxoGen, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.